SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors aggressively monitor for the 80th clinical event from the REGAL Phase 3 trial, fueling intense speculation regarding a potential buyout and short-covering momentum. The community remains deeply divided, with bulls pointing to survival plateaus as proof of efficacy while bears continue to challenge trial integrity and management's past communications.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is attracting significant investor attention as the company divests its non-core gaming division to sharpen its strategic focus on cloud and AI expansion, with the community actively debating the long-term impact of this capital reallocation. While some retail investors remain optimistic about the company's AI-driven growth potential, others are closely monitoring shareholder dilution concerns voiced by prominent investors regarding recent capital-raising activities.

TOSHI

The community is actively discussing a potential short squeeze and breakout for the asset, with many investors pointing to massive buy orders and increased social media momentum as catalysts. Traders are heavily focused on defending key support levels and looking for a major price move, fueled by speculation about upcoming exchange listings and a reversal in sentiment.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing heavy attention following a significant custom-silicon partnership with Google, which includes a multibillion-dollar warrant deal and highlights the company's role in the expanding AI infrastructure ecosystem. Investors remain highly polarized as the stock faces volatility ahead of its upcoming earnings report, with bulls focusing on long-term AI revenue potential while bears express concern over warrant dilution and the stock's tendency to struggle with price momentum.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is facing sharp downward pressure as investors react to a new $600 million at-the-market equity offering, fueling widespread concerns about share dilution. While some community members criticize the timing and management's reliance on capital raises, others argue the funding is a necessary strategic move to expand production capacity and meet surging demand for data center hardware.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as shareholders weigh strong revenue growth and raised guidance for its Briumvi franchise against an earnings miss caused by strategic manufacturing investments, fueling active speculation about a potential multi-billion dollar buyout. Community discourse remains heavily focused on the company's long-term valuation, with many long-term holders dismissive of the stock's volatility as they anticipate upcoming data readouts and a potential acquisition premium.

Ethena

Ethena is capturing significant attention as investors analyze the structural leverage provided by its high treasury concentration of tokens per share and its role in institutional crypto strategies. Community discussions are heavily focused on the potential for massive upside as the market re-rates the asset to reflect its underlying net asset value.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Investors are closely monitoring upcoming earnings and pipeline developments, with significant community discourse debating whether institutional accumulation and potential buyout interest will finally drive the stock out of its long-standing trading range.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is surging as investors react to a significant uptick in institutional ETF inflows and growing optimism surrounding potential regulatory clarity. The community remains largely bullish, actively discussing a potential breakout to higher price levels while cautioning against volatility from leveraged positions.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is trending as investors monitor sector rotations and the anticipation of upcoming biotech catalyst readouts, while community members actively debate the volatility of small-cap biotech names and potential buyout opportunities. Speculation regarding institutional accumulation and regulatory milestones for individual companies remains a central focus for the sentiment.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canadian Solar is trending as investors bet on a potential short squeeze, fueled by significant institutional buying and anticipation that U.S. manufacturing growth will unlock 45X tax credit value. Community discussion remains heavily focused on alleged market manipulation and undervalued assets, while some shareholders push for corporate action to realize the firm's true valuation.

Can T1 Energy's U.S. Solar Supply Chain Drive Its Next Phase of Growth?

TE's G2_Austin facility, domestic cell strategy and KORE Power acquisition could reshape its role in U.S. solar and storage.

Daqo New Energy (DQ) Reports Q2 Loss, Tops Revenue Estimates

Daqo (DQ) delivered earnings and revenue surprises of -328.57% and +5.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CANADIAN SOLAR ANNOUNCES RESOLUTION OF MAXEON U.S. PATENT LITIGATION

CANADIAN SOLAR ANNOUNCES RESOLUTION OF MAXEON U.S. PATENT LITIGATION CANADIAN SOLAR ANNOUNCES RESOLUTION OF MAXEON U.S. PATENT LITIGATION PR Newswire KITCHENER, ON, Aug. 18, 2026 KITCHENER, ON, Aug. 18, 2026 /PRNewswire/ -- Canadian Solar Inc. (NASDAQ: CSIQ) (the "Company" or "Canadian Solar...

Prairie Operating Co. (PROP) Q2 Earnings Top Estimates

Prairie Operating Co. (PROP) delivered earnings and revenue surprises of +500.00% and -8.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

NextNRG Inc. (NXXT) Reports Q2 Loss, Tops Revenue Estimates

NextNRG Inc. (NXXT) delivered earnings and revenue surprises of +33.33% and +18.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Recurrent Energy Secures $695 Million in Project Financing for 330 MW California Solar Project

Recurrent Energy Secures $695 Million in Project Financing for 330 MW California Solar Project Recurrent Energy Secures $695 Million in Project Financing for 330 MW California Solar Project PR Newswire KITCHENER, ON, Aug. 13, 2026 Cobalt Solar is fully permitted and under construction.KITCHENER...

E-STORAGE's KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing

E-STORAGE's KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing E-STORAGE's KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing PR Newswire KITCHENER, ON, Aug. 13, 2026 KITCHENER, ON, Aug. 13, 2026 /PRNewswire/ -- Canadian Solar Inc. (the "Company...

Recurrent Energy Powers Up Carwarp Energy Park in Australia Under Long-Term Microsoft PPA

Recurrent Energy Powers Up Carwarp Energy Park in Australia Under Long-Term Microsoft PPA Recurrent Energy Powers Up Carwarp Energy Park in Australia Under Long-Term Microsoft PPA PR Newswire KITCHENER, ON, Aug. 12, 2026 The 150 MWac solar facility near Mildura will generate enough renewable energy...

ProFrac Holding Corp. (ACDC) Reports Q2 Loss, Tops Revenue Estimates

ProFrac Holding Corp. (ACDC) delivered earnings and revenue surprises of -51.72% and +10.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SolarEdge Technologies' Q2 Earnings Top Estimates, Revenues Rise Y/Y

SEDG returns to adjusted operating profitability as stronger European demand, higher battery sales and expanding margins drive a second-quarter earnings beat.

$CSIQ Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.71 down -2.90% YoY
• Reported revenue of $1.08B down -9.92% YoY
• For Q2 2026, Canadian Solar expects total revenue between $1B and $1.2B, with gross margin from 13% to 15%. Canadian Solar reiterated 2026 guidance for U.S. solar module and battery energy storage solutions shipments.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

FLNC, CSIQ, NRGV Stocks Get Citi’s Attention Ahead Of Quarterly Earnings – Firm Says Energy Storage Demand To Drive Upside

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CSIQ Canadian Solar Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest CSIQ News